Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ciloa is dedicated to the production of fully native membrane proteins on exosomes. Based in Montpellier, France, the company was created in 2011 by Robert MAMOUN and Bernadette TRENTIN. The company is a spin-off of the CNRS and the University of Montpellier. It has exclusive proprietary technology for developing recombinant exosomes in therapeutic and preventive applications. Ciloa exosomes offer a disruptive way to dev...
Ciloa is dedicated to the production of fully native membrane proteins on exosomes. Based in Montpellier, France, the company was created in 2011 by Robert MAMOUN and Bernadette TRENTIN. The company is a spin-off of the CNRS and the University of Montpellier. It has exclusive proprietary technology for developing recombinant exosomes in therapeutic and preventive applications. Ciloa exosomes offer a disruptive way to develop a new generation of therapeutic and preventive vaccines, monoclonal antibodies, immunotherapies, and therapeutic vectors carrying drug cargo. Its unique technology allows to drug undruggable targets.

List your booth number for exhibitions, ask us